<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Forebrain cholinergic dysfunction is the hallmark of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) and Alzheimer's <z:hpo ids='HP_0000726'>dementia</z:hpo> (AD) induced by <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> during aging </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the present study is to evaluate the role of angiotensin converting enzyme (ACE) in <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e>-induced <z:hpo ids='HP_0000726'>dementia</z:hpo> and cholinergic dysfunction </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> (CHP) was induced by permanent bilateral common carotid artery (2VO) occlusion in rats </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> resulted in anterograde <z:hpo ids='HP_0002354'>memory impairment</z:hpo> revealed from <z:mp ids='MP_0001465'>Morris water maze</z:mp> (MWM) and passive avoidance step through tasks (PA), which was significantly attenuated by <z:chebi fb="2" ids="35457">ACE inhibitor</z:chebi>, <z:chebi fb="0" ids="3380">captopril</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">Cerebral hypoperfusion</z:e> down-regulated the relative expression of cholinergic muscarinic receptor (ChM-1r) and <z:chebi fb="3" ids="15354">choline</z:chebi> acetyltransferase (ChAT) as well as up-regulated the <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type-1 receptor (AT-1) expression in hippocampus of vehicle treated CHP group on the 54th day post-hypoperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>The diminished number of presynaptic cholinergic neurons and the pyramidal neurons were evident from ChAT-immunofluorescence and the <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin (H&amp;E) staining studies respectively in hippocampal Cornu ammonis1 (CA1); region of vehicle-treated hypoperfused animals </plain></SENT>
<SENT sid="6" pm="."><plain>Further the <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation level was also found to be elevated in the hippocampus of the vehicle-treated group </plain></SENT>
<SENT sid="7" pm="."><plain>Our results demonstrated that continuous <z:chebi fb="0" ids="3380">captopril</z:chebi> treatment (50 mg/kg, i.p. twice daily) for 15 days mitigated the hypoperfusion-induced cholinergic hypofunction and <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> in hippocampus </plain></SENT>
<SENT sid="8" pm="."><plain>The present study robustly reveals that the angiotensinergic system plays a pivotal role in progression of neuronal <z:hpo ids='HP_0011420'>death</z:hpo> and <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory dysfunctions</z:e> during <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> </plain></SENT>
</text></document>